Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Results by year
Filters applied: . Clear all
Page 1
Reversible Huntington's disease?
Bonelli RM, Költringer P, Kenner L, Reisecker F. Bonelli RM, et al. Lancet. 1998 Nov 7;352(9139):1520-1. doi: 10.1016/s0140-6736(05)60326-1. Lancet. 1998. PMID: 9820304 No abstract available.
Compactotomy in Huntington's chorea.
Bonelli RM, Kenner L, Gruber A, Reisecker F, Költringer P. Bonelli RM, et al. Med Hypotheses. 2001 Oct;57(4):491-6. doi: 10.1054/mehy.2001.1372. Med Hypotheses. 2001. PMID: 11601877
However, relatively few interventions were done in hyperkinetic disorders such as Huntington's disease (HD), mainly owing to the lack of an adequate target nucleus. ...We postulate that deep brain stimulation of the substantia nigra pars compacta may ameliorate hyperkinesi …
However, relatively few interventions were done in hyperkinetic disorders such as Huntington's disease (HD), mainly owing to the lack …
High-dose olanzapine in Huntington's disease.
Bonelli RM, Niederwieser G, Tribl GG, Költringer P. Bonelli RM, et al. Int Clin Psychopharmacol. 2002 Mar;17(2):91-3. doi: 10.1097/00004850-200203000-00009. Int Clin Psychopharmacol. 2002. PMID: 11890191 Clinical Trial.
The few reports available on olanzapine in Huntington's disease (HD) are insufficiently documented and/or insufficiently dosed. ...
The few reports available on olanzapine in Huntington's disease (HD) are insufficiently documented and/or insufficiently dosed. ...
Riluzole and olanzapine in Huntington's disease.
Bonelli RM, Niederwieser G, Diez J, Költringer P. Bonelli RM, et al. Eur J Neurol. 2002 Mar;9(2):183-4. doi: 10.1046/j.1468-1331.2002.0354f.x. Eur J Neurol. 2002. PMID: 11882065 No abstract available.
Pramipexole ameliorates neurologic and psychiatric symptoms in a Westphal variant of Huntington's disease.
Bonelli RM, Niederwieser G, Diez J, Gruber A, Költringer P. Bonelli RM, et al. Clin Neuropharmacol. 2002 Jan-Feb;25(1):58-60. doi: 10.1097/00002826-200201000-00011. Clin Neuropharmacol. 2002. PMID: 11852299
Levodopa is recommended as a therapeutic approach for patients with the hypokinetic-rigid, Westphal variant of Huntington's disease, but no guidelines are available for the case of nonrespondence to levodopa. ...
Levodopa is recommended as a therapeutic approach for patients with the hypokinetic-rigid, Westphal variant of Huntington's disease, …